1α,25-Dihydroxyvitamin D Downregulates Adipocyte Impact on Breast Cancer Cell Migration and Adipokine Release
Nutrients · 2024
DOI: 10.3390/nu16183153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Chaehyun Yum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Nutrition Program, Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Cell Movement, Adipocytes, Breast Neoplasms, Vitamin D. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture, NCI NIH HHS, Purdue University Center for Cancer Research.
Abstract (Originalsprache)
Background/Objectives: Excess adiposity is associated with a higher risk of breast cancer metastasis and mortality. Evidence suggests that dietary vitamin D inhibits breast cancer metastasis. However, the mechanistic link between vitamin D’s regulation of adipocyte metabolism and metastasis has not been previously investigated. Therefore, the purpose of these experiments was to examine the effect of the active form of vitamin D, 1α,25-dihydroxyvitamin D (1,25(OH)2D), on adipocyte release of bioactive compounds and whether the impact on adipocytes leads to inhibition of breast cancer cell migration, an important step of metastasis.
Methods
Differentiated 3T3-L1 adipocytes were treated with 1,25(OH)2D for two days, followed by either harvesting the adipocytes or collecting adipocyte-conditioned media without 1,25(OH)2D. A transwell migration assay was conducted with vehicle- or 1,25(OH)2D-conditioned media. In order to explore the mechanism underlying effects on breast cancer metastatic capability, the mRNA expression of leptin, adiponectin, insulin-like growth factor (IGF-1), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) was measured in adipocytes following either vehicle or 1,25(OH)2D treatment.
Results
Conditioned media from 1,25(OH)2D-treated adipocytes inhibited the migration of metastatic MDA-MB-231 breast cancer cells compared to conditioned media from vehicle-treated adipocytes. Treatment of adipocytes with 1,25(OH)2D decreased mRNA expression of leptin, adiponectin, IGF-1, IL-6, and MCP-1. Consistent with mRNA expression, concentrations of leptin, adiponectin, IGF-1, and IL-6 in adipocyte-conditioned media were decreased with 1,25(OH)2D treatment, although MCP-1 remained unchanged.
Conclusions
In summary, these results suggest that 1,25(OH)2D alters adipocyte secretions to prevent breast cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdepartmental Nutrition Program, Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
- Institute for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
ORCID-Profile: Chaylen Andolino, Dorothy Teegarden
Förderung
- United States Department of Agriculture
- NCI NIH HHS
- Purdue University Center for Cancer Research
- Indiana Clinical and Translational Sciences Institute
- Purdue University Institute for Cancer Research
- Indiana Clinical Translational Science Institute NIH/NCRR
Zitieren
APA
Yum, C., Andolino, C., Larrick, B., Sheeley, M. P., & Teegarden, D. (2024). 1α,25-Dihydroxyvitamin D Downregulates Adipocyte Impact on Breast Cancer Cell Migration and Adipokine Release. Nutrients. https://doi.org/10.3390/nu16183153
Vancouver
Yum C, Andolino C, Larrick B, Sheeley MP, Teegarden D. 1α,25-Dihydroxyvitamin D Downregulates Adipocyte Impact on Breast Cancer Cell Migration and Adipokine Release. Nutrients. 2024. doi:10.3390/nu16183153
BibTeX
@article{Yum2024,
author = {Yum, Chaehyun and Andolino, Chaylen and Larrick, Brienna and Sheeley, Madeline P and Teegarden, Dorothy},
title = {1α,25-Dihydroxyvitamin D Downregulates Adipocyte Impact on Breast Cancer Cell Migration and Adipokine Release},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16183153}
}
EUVIMED